Safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) in dogs infected with adult heartworms (Dirofilaria immitis). [PDF]
Riggs KL, Haney D, Wiseman S.
europepmc +1 more source
Efficacy of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of hookworm infections in dogs. [PDF]
Charles S +8 more
europepmc +1 more source
Multidisciplinary perspectives in Demodex blepharitis: A new view of treatment from clinical, payer, and patient perspectives. [PDF]
Page MR.
europepmc +1 more source
FDA-Approved Drugs Containing Amide Functionality in the Last Five Years (2021-2025): Pharmaceutical Use, Trends and Synthetic Approaches. [PDF]
Benedetto Tiz D.
europepmc +1 more source
Evaluation of efficacy and pharmacokinetics of novel fluralaner tablet formulation (WellPet™) in dogs. [PDF]
Cruz BC +8 more
europepmc +1 more source
A Systematic Review and Meta-Analysis of the Safety and Efficacy of 0.25% Lotilaner Ophthalmic Solution in the Treatment of Demodex Blepharitis. [PDF]
Awan B +6 more
europepmc +1 more source
Field efficacy assessment of a combination of afoxolaner, moxidectin and pyrantel pamoate to treat dogs naturally infested with Sarcoptes scabiei. [PDF]
Antoine L +5 more
europepmc +1 more source
[Simultaneous identification and detection of four novel isoxazoline drugs in bovine-origin foods using ultra-high performance liquid chromatography coupled to quadrupole/linear ion trap mass spectrometry]. [PDF]
Yang C +6 more
europepmc +1 more source
Demodex and the eye - A review. [PDF]
Chatterjee S +3 more
europepmc +1 more source

